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Abstract 
Problems with conventional treatments for a range of dermatological disorders have led scientists to search for new compounds 
of therapeutic value. Efforts have included the evaluation of natural products such as honey. Manuka honey, for example, has 
been scientifically recognised for its anti-microbial and wound healing properties and is now used clinically as a topical treatment 
for wound infections. In this review, scientific evidence for the effectiveness of honey in the treatment of wounds and other skin 
conditions is evaluated. A plethora of in vitro studies have revealed that honeys from all over the world have potent anti-
microbial activity against skin relevant microbes. Moreover, a number of in vitro studies suggest that honey is able to modulate 
the skin immune system. Clinical research has shown honey to be efficacious in promoting the healing of partial thickness burn 
wounds while its effectiveness in the treatment of non-burn acute wounds and chronic wounds is conflicted. Published research 
investigating the efficacy of honey in the treatment of other types of skin disorders is limited. Nevertheless, positive effects have 
been reported, for example, kanuka honey from New Zealand was shown to have therapeutic value in the treatment of rosacea. 
Anti-carcinogenic effects of honey have also been observed in vitro and in a murine model of melanoma.  It can be concluded 
that honey is a biologically active and clinically interesting substance but more research is necessary for a comprehensive 
understanding of its medicinal value in dermatology.  
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Commentary 
Historically, honey has been recognised around 
the world for its healing properties with records of its 
therapeutic use dating back to 2000 B.C. The ancient 
Greeks and Egyptians, for example, used honey to treat 
skin wounds and burns by applying topically on the 
skin.
1
 Honey has been reported to ameliorate a broad 
array of diseases but the focus of this review is on the 
therapeutic properties of honey in the treatment of 
disorders of the skin.  
Traditional medicine in numerous countries 
around the world has described honey as efficacious in 
the treatment of a range of skin disorders. In Malaysian 
tradition, honey is used to treat furuncles, carbuncles, 
diabetic wounds and burns. Persian traditional medicine 
documented honey as effective in the treatment of 
wounds, eczema, and inflammation.
2,3
 In Ayurvedic 
medicine, a traditional medicine native to the Indian 
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subcontinent, honey is used to treat cuts and wounds, 
eczema, dermatitis, burns, skin diseases and Fournier’s 
gangrene.
4-6
 Similarly, Quranic medicine in Pakistan 
recorded honey combined with cinnamon powder as a 
treatment for pustules, eczema, ringworm and a variety 
of other skin diseases and in Burkina Faso, Africa, it has 
been reported that indigenous people use honey as a 
skin cleansing agent and as a treatment for measles 
rash.
7,8
 The uses of honey in traditional medicine are 
still significant today, especially, when we consider the 
fact that most of the population of developing countries 
presently rely on indigenous medicine as their source of 
primary health care.
9
 Honey has also been used 
extensively as an ingredient in cosmetic skin care 
products both in the past and present day.
5,10
  
In clinical practice today, manuka honey 
produced by honey bees (Apis mellifera) feeding on the 
manuka tree (Leptospermum scoparium) in New 
Zealand is used topically in the management of wound 
infections.
11
 It has been approved for clinical use in 
Australia, New Zealand, Europe, United States of 
America, Canada and Hong Kong and products include 
γ irradiated honey in gels, ointments and impregnated 
dressings. Revamil honey is another medical grade 
honey commonly used in clinical practice for wound 
care.
12
 It is produced by manufacturers in the 
Netherlands in collaboration with the University of 
Wageningen and the Academic Medical Centre, 
Amsterdam. The manufacturers have disclosed that the 
honey is produced in greenhouses but further details 
about the origin of the honey have not been revealed. 
The skin healing ability of honey has been 
attributed to its antimicrobial properties, its ability to 
modulate the skin’s immune system and promote tissue 
repair.
13,14
 This review explores clinical and scientific 
research investigating the efficacy of honey in the 
treatment of wounds and a variety of other skin 
disorders. A principle aim was to use the scientific 
literature to evaluate the potential efficacy of honey in 
the treatment of a range of dermatological disorders. 
Methods 
The databases Pubmed, Medline and 
ScienceDirect were used to carry out a comprehensive 
search of the scientific literature on the effects of honey 
in the treatment of skin disorders including wounds. 
Some of the key search terms used in combination were 
“honey” “antimicrobial activity” “skin immune system” 
“skin disorders” “wound healing” “seborrheic 
dermatitis” “atopic dermatitis” “psoriasis” “rosacea” 
“acne” “pityriasis versicolor” “cutaneous leishmaniasis” 
“skin cancer” “ Kazakhstan” and “Central Asia”. 
Relevant in vitro and in vivo studies were selected and 
we also searched the reference list of included papers to 
ensure that no important papers were omitted. Texts in 
English, published between 1990 and 2016 were 
included.  
 
Results 
The Efficacy of Honey in the Treatment of 
Skin Wounds 
The ability of honey to aid the healing of skin 
wounds is the most widely researched aspect of honey 
as a therapeutic agent to date. A plethora of in vitro and 
in vivo studies have been performed. 
The Efficacy of Honey in the Treatment of 
Skin Wounds: In Vitro Studies 
In vitro studies have revealed that honey from 
diverse floral origins can kill a wide range of wound 
pathogens, including; methicillin resistant 
Staphylococcus aureus (MRSA), Staphylococcus 
aureus, Escherichia coli, Pseudomonas aeruginosa and 
Acinetobacter baumannii.
15-18
 As an example, the work 
of Cooper et al, (2002) demonstrated that manuka and 
pasture honey from New Zealand were active against 17 
strains of P. aeruginosa isolated from infected burns 
with minimal inhibitory concentrations (MICs) below 
10%.
19
 The authors concluded that these honeys have 
the potential to be effective treatments for burns 
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infected with P. aeruginosa. Also, Cooper et al (2014) 
later demonstrated the ability of medihoney to disrupt 
the structure and inhibit the growth of P. aeruginosa 
biofilms grown in vitro.
20
  As well as killing microbes, 
studies have shown that sub-lethal concentrations of 
honey can reduce microbial pathogenicity, for example, 
Kronda et al (2013) demonstrated that sub-lethal 
concentrations of manuka honey reduced siderophore 
production, a virulence factor that scavenges iron for 
bacterial growth, in strains of P. aeruginosa.
21
 Even 
more remarkable are the in vitro findings that honey can 
reverse antimicrobial resistance. Jenkins and Cooper 
(2012) reported that manuka honey and oxacillin 
worked synergistically to inhibit the growth of MRSA 
and that manuka honey reversed oxacillin resistance in 
MRSA in vitro.
22
  
 
Table 1. Honey as a therapeutic agent for skin disorders; 
Summary of the key in vitro findings 
 
Importantly, studies have also shown that 
honey from a variety of sources can modulate 
immunological parameters related to the skin immune 
system.
23
 For example, in vitro, honey has been shown 
to stimulate cytokine production by skin cells such as 
keratinocytes and other immune cells such as 
monocytes.
24,25
 It has been proposed that increased 
cytokine production in an early wound could enhance 
wound healing because cytokines such as TNF-α and 
IL-6 play an important role in the early wound healing 
process. Additionally, some studies have shown that 
honey or its extracts can down regulate the production 
of cellular molecules such as matrix metalloproteinases 
(MMPs) and reactive oxygen intermediates (ROIs) that 
may contribute to excessive inflammation in the chronic 
wound.
26,27
 It has been suggested that the 
immunomodulatory properties of honey may contribute 
to enhanced tissue repair or reduce chronic 
inflammation in the wound, leading to enhanced 
healing. 
As well as its antimicrobial and 
immunomodulatory properties, honey has been shown 
to promote re-epithelialisation and angiogenesis in in 
vitro models of wound healing. Ranzato et al (2012) 
demonstrated that acacia, buckwheat and manuka 
honey, purchased at an apiculture centre in Okayamo, 
Japan, increased re-epithelialisation rates in scratch 
wounds induced in keratinocyte (HaCaT) monolayers.
28
 
Furthermore, the mechanism was shown to be due to 
honey induced activation of pathways that regulate cell 
locomotion and cell proliferation. Barui et al, (2013) 
demonstrated that a honey alginate fibrous matrix 
induced faster re-epithelialisation than an alginate only 
matrix in a keratinocyte (HaCaT) wound model; E-
cadherin protein was enhanced in the honey alginate 
model which may have promoted increased cell to cell 
adhesion.
29
 Rossiter et al, (2010) reported that the 
medicinal honey Activon containing 100% manuka 
honey, the honey based ointment Mesitran as well as a 
supermarket honey (Rowse) promoted angiogenic 
activity in a rat aortic ring assay in vitro.
30
   
In conclusion, in vitro studies have revealed 
that honey has some remarkable scientific properties 
that, plausibly, could promote the healing of wounds.  
The Efficacy of Honey in the Treatment of 
Skin Wounds: In Vivo Studies 
Ideally, a wound will heal early but sometimes 
wound healing is delayed and this can be the result of 
systemic disease, malnutrition and infection of the 
wound leading to excessive inflammation. Indeed, 
excessive infiltration of neutrophils has been associated 
with deficient wound healing.
31
 Micro-organisms can 
sometimes attach to the wound bed and form a biofilm 
which is disruptive to the healing process. Wound 
infections exacerbate illness, cause anxiety and increase 
patient morbidity and mortality. Surgical wound 
infections lengthen hospital stay and chronic wounds 
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require considerably more dressings. Hence, effective 
prevention and management of wound infections will 
impact positively on both patient health and cost. 
 
Table 2. Honey as a therapeutic agent for skin disorders; 
Summary of the key in vivo findings 
 
There are a plethora of in vivo studies 
investigating the efficacy of honey in the treatment of 
wounds;
32-55
 many of the findings are controversial. 
However, a recent Cochrane based review by Jull et al, 
(2015)
56
 concluded that there is quality evidence that 
honey heals partial thickness burn wounds more quickly 
than conventional treatments and infected post-
operative wounds more effectively than gauze or 
antiseptics. It was concluded that other studies 
comparing honey with conventional methods in wound 
healing were of insufficient quality to form any 
definitive conclusions.  
Larger, well designed, double blind, clinical 
studies are required for a fuller understanding of the 
efficacy of honey in the treatment of different types of 
wounds.  The mechanism of the skin healing properties 
of honey in relation to burn wounds is not fully 
understood but may, at least partially, be due to the 
antioxidant content of honey. There is evidence for free 
radical activity and reduced antioxidant scavenging 
capacity in burn wounds leading to oxidative stress.
57
 
Honeys that are rich in antioxidants are likely to 
increase the antioxidant capacity of burn wounds and 
mop up free radicals leading to reduced oxidative 
stress.
58
 Of course, the antimicrobial and 
immunomodulatory properties of honey may also 
positively encourage the wound healing process in burn 
wounds.  
Mode of administration and combination 
therapy with other agents such as antibiotics or other 
natural products could be considered. Techniques such 
as checkerboard and time kill studies are currently being 
used to determine the synergistic effects of 
antimicrobial agents (personal communication; 
Oluwadun A. & Akinduti P., Olabisi Onabanjo 
University). 
The Efficacy of Honey in the Treatment of 
Other Disorders of the Skin 
In Vitro Studies 
In vitro studies have revealed that honey can 
inhibit the growth of a range of dermatologically 
important microbes. As well as inhibition of microbes 
responsible for wound infections, honey has been shown 
to inhibit the growth of dermatophytes a cause of tinea 
infections, Candida albicans a cause of cutaneous 
candidiasis and Propionibacterium acnes a cause of 
acne.
16,59-61 
Many studies have demonstrated the 
antimicrobial effects of honey from a variety of sources 
against S. aureus. As well as wound infections S. aureus 
is an important cause of furuncles, styes and impetigo 
and super-infection with S. aureus is common in atopic 
dermatitis.
62`
 Research should continue to investigate 
the in vitro effects of honey against other 
dermatologically important microbes such as 
Malassezia species, human papilloma virus and Bacillus 
oleronius. 
Some skin disorders such as contact dermatitis, 
atopic dermatitis and psoriasis have been classified as 
immune mediated skin disorders. Although the 
aetiology of the majority of immune mediated skin 
disorders are not fully understood the immune system is 
believed to play a significant role in the pathogenesis of 
the disease. Such disorders commonly respond to 
treatment with immunomodulating agents such as 
corticosteroids or ultraviolet radiation therapy. 
Recently, in vitro studies have revealed that honey is 
able to modulate the immune system, for example, a 
study by Majtan et al, (2010) demonstrated that acacia 
honey from Slovakia stimulated TNF-α, TGF-β, IL-1β 
and matrix metalloproteinase 9 (MMP-9) mRNA 
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expression by human primary keratinocytes isolated 
from human foreskin.
24
 Subsequently, Majtan et al, 
(2013) reported that an aqueous extract of fir honeydew 
honey from Slovakia inhibited TNF-α induced matrix 
metalloproteinase-9 (MMP-9) protein and mRNA 
production by human keratinocytes (HaCaT) cells.
27
 
Since the role of the immune system in skin disorders is 
complex, it is difficult to infer what effects honey will 
have in the treatment of immune mediated skin 
disorders without further investigation. It is likely that 
both the origin of the honey and the microenvironment 
of the skin disorder will influence clinical outcome.  
Clearly, more research is necessary for a better 
understanding of the immunomodulatory properties of 
honey and their relevance for skin disease.  
The Efficacy of Honey in the Treatment of 
Other Disorders of the Skin: In Vivo Studies 
The majority of clinical studies performed to 
date have investigated the efficacy of honey in the 
treatment of skin wounds. There is a paucity of clinical 
studies investigating the effects of honey on other types 
of skin disorders; however, some of the studies that 
have been carried out have produced positive results. 
Al-Waili (2001) reported a remarkable improvement of 
symptoms in patients with seborrheic dermatitis (n=30) 
following topical application of a diluted crude honey 
(90%).
63
 The same researcher, later reported that a 
honey mixture containing natural honey of multi-floral 
origin from Lootah Farm, Al-Theed City, United Arab 
Emirates, olive oil and beeswax (1:1:1) markedly 
improved the symptoms of patients with atopic 
dermatitis (n=21) and psoriasis (n=18).
64
 Some of the 
psoriatic and atopic dermatitis patients received a honey 
mixture treatment in combination with corticosteroids 
and this allowed the concentration of corticosteroid to 
be reduced over time without exacerbation of 
symptoms. Al-Waili, (2003) suggested that the anti-
microbial, anti-inflammatory and antioxidant properties 
of honey may explain the observed therapeutic effects. 
The same honey mixture was found to cure the 
symptoms of the fungal skin infections pityriasis 
versicolor in 79% of patients (n=14), tinea cruris in 71% 
of patients (n=14) and tinea corporis in 62% of patients 
(n=8).
65
 In 2005, Al-Waili reported that the same honey 
mixture significantly reduced mean lesion scores in 
infants with diaper dermatitis (n=12); the presence of C. 
albicans was found to be reduced in some patients 
treated with the honey mixture.
66
 In a small study 
(n=16) by Al-Waili (2004) it was reported that honey 
was more effective than acyclovir in the treatment of 
patients with labial and genital herpes simplex lesions, 
suggesting that honey could potentially be effective in 
the treatment of oral herpes simplex lesions.
67
 
 
Table 3. Studies investigating the efficacy of honey in 
the treatment of skin disorders (excluding wounds) 
 
Acasia honey (Yamada bee farm, Japan) and 
the bee product Brazilian green propolis (BPE) have 
also been shown to be efficacious in the treatment of 
tinea infections in vivo.
68
 Two hundred and forty two 
Congolese school children with either tinea capitis or 
pityriasis versicolor were treated with either 2% 
Miconazole (positive control), BPE (100mg/ml or 
50mg/ml), acasia honey or Vaseline. The results showed 
that acasia honey, BPE at both concentrations and 
Miconazole significantly improved erythema, 
desquamation and pruritis in tinea patients in 
comparison to Vaseline.   
Rosacea is an inflammatory skin disorder, 
characterised by facial redness, papules, pustules and 
telangiectasia. The bacterium Bacillus oleronius isolated 
from the Dermodex folliculorum mite has been 
implicated in the aetiology of the disease. A recent 
study by Braithwaite et al (2015) has shown that kanuka 
honey from New Zealand was efficacious in the 
treatment of rosacea.
69
 Their study included 138 
participants with a diagnosis of rosacea and a Global 
Assessment of Rosacea Severity Score (IGA-RSS) of ≥ 
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2.69. Sixty nine participants were treated with topical 
Honevo (90% kanuka honey and 10% glycerine) for 8 
weeks. The other 69 participants were treated with the 
control cream Cetomacrogol, a moisturising cream, 
commonly used as a vehicle for delivering topical 
medications. The results showed that 34.3% in the 
Honevo group and 17.4% in the control group had a ≥ 2 
improvement in the IGA-RSS at week 8. The 
researchers concluded that Honevo is an effective 
treatment for rosacea and that future research should 
compare Honevo with other conventional treatments, 
such as topical Metronidazole and Azelaic cream, both 
of which have limited efficacy. The mechanisms of the 
therapeutic properties of kanuka honey in the treatment 
of rosacea are not fully understood but both the anti-
bacterial and anti-inflammatory properties have been 
considered.  
A recent study involving 136 participants with 
acne (Investigators Global Assessment (IGA) score of ≥ 
2.68 aged between 16 and 40 years was carried out to 
investigate the efficacy of topical kanuka honey in the 
treatment of acne.
70 
 Sixty eight of the participants were 
randomised to a treatment regime which involved 
applying Protex, a trilocarbon-based antibacterial soap 
twice daily for 12 weeks whilst the other 68 participants 
applied the anti-bacterial soap treatment followed by 
application of Honevo directly after washing off the 
bacterial soap, twice daily for 12 weeks. The results 
demonstrated that 4 out of 53 patients (7.6%) in the 
honey treated group and 1 out of 53 (1.9 %) patients in 
the anti-bacterial soap only treated group had a ≥ 2 
improvement in IGA score. The authors concluded that 
there was no evidence that adding Honevo to standard 
anti-bacterial soap treatment for acne is more 
efficacious than anti-bacterial soap alone. The authors 
however did raise concerns about treatment compliance 
due to the young age of many of the participants and the 
high rate of withdrawal. Medical grade kanuka honey 
has also been tested for its efficacy in the treatment of 
eczema and psoriasis.
71,72
 No evidence of effectiveness 
in the treatment of eczema above that of an aqueous 
control cream was reported. The study involved 15 
participants with bilateral eczematous lesions on the 
limbs; medical grade kanuka honey was applied to a 
representative lesion on one side and aqueous cream BP 
to the other, every night for 2 weeks.  Aqueous cream is 
not a recommended treatment for eczema and therefore 
represented a negative control. The authors concluded 
that their study did not demonstrate any evidence that 
kanuka honey is an effective treatment for eczema, 
however, the small sample size and incomplete blinding 
were acknowledged as limitations of the study. The 
same study design was also used to investigate the 
efficacy of kanuka honey in the treatment of psoriasis. 
The results showed that kanuka honey was of similar 
efficacy to aqueous cream; a recommended treatment 
for psoriasis but with lower efficacy than 
corticosteroids. Medical grade kanuka honey has also 
been tested for its efficacy in the treatment of cold sores 
and compared with Acyclovir.
73
 The study showed that 
Kaplan-Meier estimates of median healing time were 
similar for honey and Acyclovir. However, limitations 
of the study were that participant size was small with 
only 15 patients; the authors proposed that a larger 
clinical study should be conducted.   
Naidoo et al (2011) tested the efficacy of 
manuka honey as a prophylactic treatment for dermatitis 
in a phase II randomised controlled trial involving 
patients undergoing radiation therapy for breast 
cancer.
74
 81 patients were enrolled in the study; 43 of 
which were treated with manuka honey and 38 with 
standard aqueous cream. The results showed that there 
was a lower incidence of grade >2 dermatitis in the 
patients treated with honey (37.2%) compared with 
those treated with aqueous cream (57.8%). When > 
grade 2 dermatitis did occur the duration was shorter in 
the honey treated group in comparison to the group 
treated with aqueous cream.   
One study also investigated the therapeutic 
value of honey in the treatment of cutaneous 
leishmaniasis.
75
 In this study, 90 patients with cutaneous 
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leishmaniasis were allocated to a treatment regime; 45 
patients were treated for 6 weeks with topical honey 
soaked gauze twice daily and intra-lesional injection of 
glucantime weekly. The other 45 patients were treated 
with intra-lesional injection of glucantime only.  By the 
end of the treatment more patients had complete cure in 
the glucantime only treated group (71%) than in the 
glucantime and honey treated group (51.1%), suggesting 
that the honey used in this study is not of therapeutic 
value in the treatment of cutaneous leishmaniasis.   
The aforementioned studies investigating the 
efficacy of honey in the treatment of other types of skin 
disorders are relatively small scale and several of them 
have been carried out by the same researcher, 
nevertheless, they support the possibility that honey 
may be therapeutic in the treatment of other types of 
skin disorder such as fungal skin infections and 
inflammatory skin conditions. Systematic reviews are 
important for evidence based method and this approach 
has been adopted by Jull et al (2015)
56
 to evaluate the 
efficacy of honey in the treatment of wounds. Clinical 
studies investigating the efficacy of honey in the 
treatment of other types of skin disorders are more 
limited and we have described all published findings 
irrespective of the quality of the study design. It is 
important that all future studies carried out follow 
international standards for clinical trial reporting. 
Undoubtedly, further research is necessary, 
incorporating in vitro, animal and clinical studies to 
determine the medical value of honey in the treatment 
of a range of dermatological disorders. Even if honey is 
found to be an ineffective treatment for certain skin 
diseases such studies are important because the 
knowledge will inform patients and clinicians 
considering alternative therapies for dermatological 
disorders.  
Honey and Skin Cancer 
Recently, Fernandez-Cabezudo et al, (2013) 
reported that manuka honey could inhibit the 
proliferation and induce apoptosis in three cancer cell 
lines, one of which was the murine melanoma cell line 
B16.F1.
76
 Additionally, Pichichero et al, (2010) 
reported that acacia honey inhibited proliferation of 
murine and human melanoma cells by inducing cell 
cycle arrest at G0/G1.
77
  In vivo, a murine melanoma 
tumour model treated with intravenous manuka honey 
displayed a significant reduction in tumour growth.
76
 
Some of the mice received co-administration of manuka 
honey and the chemotherapeutic drug taxol and this 
resulted in a significant inhibition of the growth of the 
tumour and improved overall animal survival suggesting 
that manuka honey, as well as having anti-tumourogenic 
properties, may reduce chemotherapy induced toxicity. 
No changes in haematological and chemical markers 
were observed in the mice treated with intravenous 
manuka honey suggesting that it is safe to administer 
honey in this way.  In another study, tualang honey from 
Malaysia was shown to protect murine keratinocytes 
(PAM 212 cells) in vitro from the immunomodulatory 
and photocarcinogenic effects of UVB radiation.
78
 UVB 
irradiated keratinocytes treated with honey exhibited 
reduced expression of COX-2 and NF-κB activation in 
comparison to UVB only treated cells. Furthermore, 
UVB irradiated keratinocytes treated with tualang honey 
displayed a marked reduction in DNA damage in the 
form of cyclobutane pyrimidine dimers and 8-oxo-7, 8-
dihydro-2-deoxyguanosine compared with UVB 
irradiated controls. Tualang honey may therefore be 
able to protect the skin against the immunomodulatory 
and photocarcinogenic effects of sunlight exposure.  
The ability of honey to inhibit the proliferation 
of tumour cells is thought to be due to the various 
flavonoid and phenolic compounds present in honey. 
Evidence for this comes from the work of Pichichero et 
al, (2010; 2011) showing that chrysin, a flavanoid found 
in acacia honey inhibited proliferation of melanoma 
cells via cell cycle arrest and apoptosis.
77,79
 Honey has 
also been shown to regulate expression of p53, the 
tumour suppressor protein and down regulate Bcl-2 an 
anti-apoptotic protein, found at high levels in numerous 
cancers.
80
 The anti-inflammatory effects of honey may 
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also contribute to its anti-carcinogenic properties, 
particularly as inflammation has been shown to 
contribute to the progression of cancer.
81
 
The anti-carcinogenic properties of honey 
observed to date are promising but more research is 
necessary, particularly in vivo, for a fuller understanding 
of the potential efficacy of honey in the treatment or 
prevention of skin cancer.  
  
Discussion 
The ability of honey in vitro to kill skin 
relevant microbes, alter microbial pathogenicity, reverse 
antibiotic resistance, modulate immunological 
parameters, promote tissue repair, inhibit tumour cell 
growth and protect against UV induced DNA damage is 
really quite remarkable considering it is a scientifically 
unaltered, purely natural substance produced by bees. In 
vitro studies have sparked excitement amongst 
researchers about the therapeutic potential of honey for 
clinical practice. Some of the properties observed in 
vitro are particularly relevant today when the current 
global crisis of antimicrobial drug resistance has 
rendered many infectious diseases, including wound 
infections, untreatable and malignant melanoma 
incidence is increasing faster than any other cancer.
82,83
 
Skin Cancer is also a significant problem in Central 
Asian countries; in Kazakhstan for example, incidence 
figures from the Ministry of Health (2013) show that 
skin cancer is one of the most common forms of cancer 
along with lung and breast cancer.
84
 Furthermore, a 
particularly high incidence of basal cell carcinomas was 
recorded around the Semipalatinsk nuclear testing site 
in Kazakhstan.
85 
There are countless varieties of honey being 
produced worldwide and some may have superior 
healing abilities that are yet to be discovered. Central 
Asia possesses a unique biodiversity with open steppe, 
deserts and high mountains; honey production is 
abundant in Kazakhstan, Kyrgyzstan, Uzbekistan and 
Tajikistan. Beekeeping trailers enable honey producers 
to reach diverse locations in the region, despite this, the 
regions honeys have not been fully examined for 
potential biomedical uses. Other local bee products, 
such as propolis could also be investigated for their 
medicinal value as research has demonstrated 
antimicrobial,
 
anti-carcinogenic and wound healing 
properties.
86-88
 The development of locally produced 
honeys into medical grade honeys suitable for use in 
clinical practice could be economically advantageous 
for the country concerned. 
A recent review has highlighted that there is no 
statistical monitoring on the prevalence of chronic 
wounds in Kazakhstan and no approved protocols for 
wound care.
89
 The authors described that wound care 
products made from plant extracts have been developed 
in Kazakhstan although they have not been officially 
approved for clinical use. The review did not list honey 
as a treatment used for wound care in Kazakhstan 
despite its approved use in other parts of the world.  
In conclusion, research has demonstrated that 
the bioactive properties of honey and the aetiology of 
skin diseases are complex and that there are 
considerable gaps in our knowledge and understanding 
of both. Innovative research that can maximally exploit 
the bioactive properties of this natural substance may in 
the future lead to the production of a medicinal product 
that is highly valued in dermatology.  
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Table 1: Honey as a therapeutic agent for skin disorders; Summary of the key in vitro 
findings 
Key References 
 
Key Findings (in vitro) 
14-17,59-61,90,91 Honeys from around the world have potent antimicrobial activity 
against skin relevant microbes. 
  
22 Honey can reverse antimicrobial resistance. 
  
21,92-94 Pathogenicity of skin relevant microbes is reduced by honey. 
  
23-25,95-99 Honey modulates cytokine production by cells of the skin immune 
system.  
  
26,27,58,100 Anti-inflammatory effects of honey are observed in vitro. 
  
28-30
 Honey promotes re-epithelialisation and angiogenesis in in vitro 
wound models. 
  
76-78 Honey induces apoptosis of a murine melanoma cell line and 
protects keratinocytes from the photocarcinogenic effects of UVB 
radiation. 
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Table 2: Honey as a therapeutic agent for skin disorders; Summary of the key in vivo 
findings 
Key References 
 
Key Findings (in vivo) 
56 Clinical studies suggest that topical application of honey is more 
efficacious than conventional treatments in healing partial thickness burn 
wounds. 
  
34,36-38,43,45,46,53
 The efficacy of honey in the treatment of non-burn acute wounds and 
chronic wounds is controversial. 
  
 63-66,68,69 Limited human studies suggest that honey is therapeutic in the treatment 
of some inflammatory skin disorders and fungal skin infections. 
  
76 Honey reduces tumour growth in a murine melanoma model. 
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Table 3: Studies investigating the efficacy of honey in the treatment of skin disorders 
(excluding wounds) 
Population Honey Application Outcome Ref. 
37 patients; 14 with 
pityriasis versicolor, 8 
with tinea corporis, 14 
with tinea cruris and 1 
with tinea faciei 
Honey mixture containing honey, olive oil 
and beeswax (1:1:1) applied to the lesions 
3 times daily for a maximum of 4 weeks. 
Honey was multi-floral from the United 
Arab Emirates. 
Complete cure obtained in 79% of 
patients with pityriasis versicolor; 
71% of patients with tinea cruris and 
62% of patients with tinea corporis.  
Patient with tinea faciei obtained 
clinical cure 3 weeks after start of 
therapy.  
65
 
242 Congolese school 
children with either 
tinea capitis or 
pityriasis versicolor 
Treated with either 2% Miconazole, 
Brazilian green propolis extract or acasia 
honey (Yamada bee farm, Japan) or 
Vaseline. 
Acasia honey (p < 0.05), Brazilian 
green propolis extract (p < 0.05) and 
2% Miconazole (p < 0.01) 
significantly improved erythema, 
desquamation and pruritis in tinea 
patients in comparison to Vaseline.  
68
 
10 patients with atopic 
dermatitis 
Lesions on the right side of the body 
treated with vaseline. Lesions on the left 
side of the body treated with a multifloral 
honey mixture, containing honey beeswax 
and olive oil in a ratio of 1:1:1 for 2 
weeks. Each treatment was applied three 
times daily. Honey was from the United 
Arab Emirates.  
Significant improvement was seen in 
lesion scores on the left side of the 
body in 8 out of the 10 patients.  
64
 
8 patients with 
psoriasis 
Lesions on the right side of the body were 
treated with paraffin and lesions on the left 
were treated with honey mixture (as 
described above), 3 times daily for 3 
weeks. 
Significant improvement was seen in 
lesion scores on the left side of the 
body in 5 out of 8 patients.  
64
 
12 infants with diaper 
dermatitis 
Topical application 4 times daily with a 
multifloral honey mixture containing 
honey, beeswax and olive oil in a ratio of 
1:1:1 for 7 days. 
Mean total rash score at baseline was 
2.91 ± 0.79. Decreased to 0.66 ± 0.98 
at day 7. At the end of the study 10 of 
the 12 infants had either mild or no 
diaper dermatitis. 
66
 
81 patients undergoing 
radiation therapy for 
breast cancer 
Prophylatic treatment: 43 treated with a 
pure sterilized manuka honey UMF=18. 
Thirty eight patients treated with standard 
aqueous cream. Topical treatments were 
applied twice daily starting on day 1 of 
radiation and continued until 10 days post 
treatment.  
Lower incidence of > grade 2 
dermatitis in the patients treated with 
honey (37.2%) compared with those 
treated with aqueous cream (57.8%). 
When ≥ grade 2 dermatitis did occur 
duration was shorter in honey treated 
group.  p = 0.08 
74
 
138 patients with 
rosacea (IGA-RSS)  ≥ 
2.69 
69 patients treated with topical application 
of Honevo (90% kanuka honey and 10% 
glycerine) for 8 weeks. 69 patients treated 
with the control cream Cetomacrogol.  
34.3 % in the Honevo group and 
17.4% in the control group had a ≥ 2 
improvement in the IGA-RSS at 
week 8. p = 0.02 
69
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136 patients aged 16-
40 years with acne 
IGA ≥ 2.68 
68 participants applied Protex, a 
trilocarbon based antibacterial soap twice 
daily for 12 weeks. Another 68 
participants followed the antibacterial soap 
treatment regime and applied Honevo 
(90% kanuka honey and 10% glycerine) 
directly after washing off the anti-bacterial 
soap, twice daily for 12 weeks.  
4/53 (7.6%) of participants in the 
honey group and 1/53 (1.9%) in the 
control group had a ≥ 2 improvement 
in IGA score at week 12. Trial did 
not show evidence that adding 
Honevo to the antibacterial soap 
regime was more effective than soap 
alone.  
70
 
15 patients with 
bilateral eczematous 
lesions on the limbs 
Medical grade kanuka honey was applied 
to a representative lesion on one side and 
aqueous cream BP on the other, every 
night for 2 weeks.  
Kanuka honey was not more 
efficacious than aqueous cream BP in 
the treatment of eczema. Aqueous 
cream BP is not a recommended 
treatment for eczema. 
71
 
15 patients with 
psoriasis with bilateral 
lesions on the limbs. 
Medical grade kanuka honey was applied 
to a representative lesion on one side and 
aqueous cream BP on the other, every 
night for 2 weeks.  
Efficacy was similar to that of the 
aqueous cream which is a 
recommended treatment for psoriasis.  
72
 
15 participants aged 16 
or over with recurrent 
Herpes Simplex 
Labialis 
Participants applied either medical grade 
kanuka honey or acyclovir to the lesion 5 
times per day until the lesion resolved.  
Kaplan-meier estimates of median 
healing time were similar for honey 
and acyclovir.  
73
 
90 patients with 
cutaneous 
leishmaniasis 
45 patients treated with topical honey 
twice daily along with intra-lesional 
injection of glucantime once weekly for a 
maximum of 6 weeks. 45 patients treated 
with glucantime only.  
More patients had complete cure in 
the glucantime only treated group 
(71%) than in the glucantime and 
honey treated group (51%). p = 0.04 
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